4 stories mentioning CRBPUpdated just now
Every FINWIRES story that references CRBP, newest first.
Corbus Pharmaceuticals (CRBP) has an average rating of buy and mean price target of $36.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $8.64, Change: $+0.33, Percent Change: +3.97%
(Updated to keep price target unchanged).Corbus Pharmaceuticals Holdings Inc (CRBP) has an average rating of buy and mean price target of $41.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $10.06, Change: $+0.24, Percent Change: +2.44%
Corbus Pharmaceuticals Holdings Inc (CRBP) has an average rating of buy and mean price target of $41.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $9.87, Change: $+0.04, Percent Change: +0.46%
Corbus Pharmaceuticals Holdings Inc (CRBP) has an average rating of buy and mean price target of $41.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
